| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 394.225 | 90 |
| GSM780708 | Untreated after 4 days (C2_1) | 440.546 | 91 |
| GSM780709 | Untreated after 4 days (C3_1) | 348.215 | 89 |
| GSM780719 | Untreated after 4 days (C1_2) | 346.371 | 89 |
| GSM780720 | Untreated after 4 days (C2_2) | 437.553 | 91 |
| GSM780721 | Untreated after 4 days (C3_2) | 338.009 | 88 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 408.284 | 90 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 389.996 | 90 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 396.705 | 90 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 410.576 | 90 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 373.61 | 89 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 397.81 | 90 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 322.312 | 88 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 346.291 | 89 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 355.026 | 89 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 341.662 | 89 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 361.813 | 89 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 371.564 | 89 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 422.383 | 90 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 419.196 | 90 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 401.629 | 90 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 424.291 | 90 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 442.285 | 91 |